BusinessActinium Pharmaceuticals Appoints Jeannine Larrieux, Ph.D. as Director of Analytical Development to Support BLA and IND Enabling Analytical Studies for Current and Future Clinical ProgramsBy Nasdaq OMXDec 19, 2016, 12:00 PM UTC
BusinessAmerican Health Council Names Carlos Encarnacion, M.D. to Physician BoardBy Nasdaq OMXDec 14, 2016, 4:37 PM UTC
BusinessActinium Pharmaceuticals Announces Submission of EU Orphan Designation Application for Actimab-ABy Nasdaq OMXDec 13, 2016, 12:00 PM UTC
BusinessActinium to Sponsor Upcoming Blood & Marrow Transplant Information Network Webinar Focused on Stem Cell Transplants for Patients with AMLBy Nasdaq OMXDec 12, 2016, 12:00 PM UTC
BusinessAmerican Health Council Names Julie Hammon, MSN, RN, OCN to Nursing BoardBy Nasdaq OMXDec 8, 2016, 5:03 PM UTC
BusinessActinium Highlights Results from Phase 1 Clinical Trial of Actimab-A at 58th American Society of Hematology Annual MeetingBy Nasdaq OMXDec 6, 2016, 2:00 AM UTC
BusinessActinium Further Strengthens Clinical Development Team with Senior Hire to Support Later-Stage Clinical TrialsBy Nasdaq OMXNov 29, 2016, 12:00 PM UTC
BusinessActinium Issues Letter to Shareholders Highlighting 2016 Accomplishments and Anticipated Milestones for 2017By Nasdaq OMXNov 22, 2016, 12:00 PM UTC
